EP Wealth Advisors LLC acquired a new stake in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 7,710 shares of the company's stock, valued at approximately $248,000.
A number of other hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. raised its stake in Keurig Dr Pepper by 23.6% during the 4th quarter. Vanguard Group Inc. now owns 119,587,162 shares of the company's stock valued at $3,841,140,000 after acquiring an additional 22,856,757 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of Keurig Dr Pepper by 10.3% in the 4th quarter. Wellington Management Group LLP now owns 60,602,781 shares of the company's stock worth $1,946,561,000 after acquiring an additional 5,646,179 shares during the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Keurig Dr Pepper by 36.0% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company's stock worth $1,755,564,000 after acquiring an additional 14,473,054 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Keurig Dr Pepper by 8.7% in the 4th quarter. Geode Capital Management LLC now owns 24,511,039 shares of the company's stock worth $784,974,000 after acquiring an additional 1,962,195 shares during the last quarter. Finally, Invesco Ltd. grew its holdings in shares of Keurig Dr Pepper by 19.6% during the fourth quarter. Invesco Ltd. now owns 21,605,610 shares of the company's stock valued at $693,972,000 after buying an additional 3,539,463 shares in the last quarter. Institutional investors and hedge funds own 93.99% of the company's stock.
Insider Buying and Selling at Keurig Dr Pepper
In other news, VP Angela A. Stephens sold 14,500 shares of the stock in a transaction that occurred on Wednesday, May 7th. The stock was sold at an average price of $34.24, for a total value of $496,480.00. Following the completion of the transaction, the vice president now directly owns 62,411 shares of the company's stock, valued at approximately $2,136,952.64. This represents a 18.85% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, major shareholder Bevco B.V. Jab sold 83,950,000 shares of the stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $32.65, for a total value of $2,740,967,500.00. Following the completion of the transaction, the insider now directly owns 134,113,479 shares of the company's stock, valued at approximately $4,378,805,089.35. The trade was a 38.50% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 84,863,850 shares of company stock valued at $2,772,203,450 in the last quarter. Corporate insiders own 0.40% of the company's stock.
Keurig Dr Pepper Stock Performance
Keurig Dr Pepper stock traded up $0.28 during trading hours on Friday, hitting $33.82. The stock had a trading volume of 8,578,351 shares, compared to its average volume of 10,534,553. The company has a 50-day moving average of $34.22 and a two-hundred day moving average of $33.01. The company has a quick ratio of 0.36, a current ratio of 0.53 and a debt-to-equity ratio of 0.50. The company has a market cap of $45.93 billion, a PE ratio of 20.50, a price-to-earnings-growth ratio of 2.42 and a beta of 0.52. Keurig Dr Pepper Inc. has a fifty-two week low of $30.12 and a fifty-two week high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last posted its quarterly earnings results on Thursday, April 24th. The company reported $0.42 EPS for the quarter, beating the consensus estimate of $0.38 by $0.04. The firm had revenue of $3.64 billion during the quarter, compared to analysts' expectations of $3.57 billion. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The company's revenue for the quarter was up 4.8% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.38 EPS. On average, equities research analysts anticipate that Keurig Dr Pepper Inc. will post 1.92 EPS for the current fiscal year.
Wall Street Analyst Weigh In
KDP has been the topic of a number of research analyst reports. Argus began coverage on Keurig Dr Pepper in a report on Wednesday, April 16th. They set a "buy" rating and a $40.00 price target on the stock. HSBC raised Keurig Dr Pepper from a "hold" rating to a "buy" rating and lifted their price objective for the company from $36.00 to $42.00 in a research report on Friday, April 25th. JPMorgan Chase & Co. lifted their price objective on Keurig Dr Pepper from $37.00 to $40.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. UBS Group lifted their price objective on Keurig Dr Pepper from $40.00 to $42.00 and gave the company a "buy" rating in a research report on Thursday, April 17th. Finally, Barclays lifted their price objective on Keurig Dr Pepper from $37.00 to $38.00 and gave the company an "overweight" rating in a research report on Monday, April 28th. Four research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $39.33.
Check Out Our Latest Analysis on Keurig Dr Pepper
Keurig Dr Pepper Company Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Further Reading

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report